Gaucher Disease, Type 2
Rare Disease·MeSH: Gaucher Disease
Prevalence
0.5 / 100K
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1/Phase 2(1)
| Drug | Company |
|---|---|
| ly3884961 | Prevail Therapeutics Inc. (PRVL) |
Frequently asked questions
How many drugs are in development for Gaucher Disease, Type 2?
BioSniper tracks 1 drug in development for Gaucher Disease, Type 2 across 1 company.
How many clinical trials target Gaucher Disease, Type 2?
There are 1 clinical trial targeting Gaucher Disease, Type 2 tracked by BioSniper.
What is the prevalence of Gaucher Disease, Type 2?
The estimated prevalence of Gaucher Disease, Type 2 is approximately 0.5 per 100,000 population.
Deep-dive into Gaucher Disease, Type 2
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis